1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsRE-JOIN Consortium (Forecasted Opportunity) is sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) in conjunction with other NIH Institutes and Centers (ICs). This opportunity supports mission-aligned projects and measurable outcomes.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Opportunity Listing - Restoring Joint Health and Function to Reduce Pain (RE-JOIN) 2. 0 Restoring Joint Health and Function to Reduce Pain (RE-JOIN) 2. 0 Agency: National Institutes of Health Assistance Listings: 93.
846 -- Arthritis, Musculoskeletal and Skin Diseases Research Last Updated: May 13, 2026 View version history on Grants.
gov The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), in conjunction with other NIH Institutes and Centers (ICs) as a part of the congressionally mandated NIH Helping to End Addiction Long Term (HEAL) initiative intends to publish a Notice of Funding Opportunity (NOFO) to leverage and accelerate the progress achieved in the Restoring Joint Health and Function to Reduce Pain (RE-JOIN) Consortium.
The NOFO aims to more fully refine and map the innervation of the different articular and peri-articular tissues that collectively form the joint (including bone, cartilage, synovium, joint capsule, ligament, tendon, fascia and muscle), by sensory neurons that mediate the sensation of pain.
The NOFO seeks to expand initial and ongoing efforts by: Enhancing clinical pain phenotyping with multimodal profiling of new and expanded patient samples across life span and disease conditions (i.e., other musculoskeletal and/or rheumatic conditions associated with joint pain beyond knee and temporomandibular joint (TMJ)). Expanding to new preclinical and New Approach Methodologies (NAMs) in modeling joint disease.
Preclinical testing of novel joint-targeted candidates identified in RE-JOIN 1. 0. Focusing on peri-articular tissues in joint pain, such as vasculature, synovium, adipose, myofascial tissue, etc. Prioritizing secondary analysis of datasets and/or validation of methods and approaches in human samples.
Improve data integration by developing/enhancing joint atlases that will enable integration of imaging and molecular datasets. Applications are not being solicited at this time. Notice is being provided to allow potential applicants sufficient time to develop meaningful multidisciplinary collaborations and responsive projects.
Investigators with expertise and insights in neurobiology, pain science, data science, orthopedics, rheumatic disease, etc. are encouraged to consider applying for this NOFO.
Private institutions of higher education Public and state institutions of higher education Independent school districts Nonprofits non-higher education without 501(c)(3) Other Native American tribal organizations Nonprofits non-higher education with 501(c)(3) Special district governments Federally recognized Native American tribal governments City or township governments Public and Indian housing authorities For-profit organizations other than small businesses Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
Grantor contact information National Institute of Arthritis and Musculoskeletal and Skin Diseases Please contact via e-mail. No documents are currently available.
Link to additional information Estimated Application Due Date : Estimated Due Date Description : Estimated Project Start Date : Funding opportunity number : Cost sharing or matching requirement : Funding instrument type : Opportunity Category Explanation : Category of Funding Activity : Your account requires additional identity verification.
According to the current listing, eligibility includes: Investigators with expertise and insights in neurobiology, pain science, data science, orthopedics, rheumatic disease, etc. , are encouraged to consider applying. Universities are eligible. Confirm the full requirements in the official notice before applying.
RE-JOIN Consortium (Forecasted Opportunity) is funded by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) in conjunction with other NIH Institutes and Centers (ICs). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
ARPA-H launched SPECTRA on September 17, 2026 under solicitation ARPA-H-SOL-26-163 — four technical areas with separate Solution Summary deadlines on October 18, December 2, and January 18. The enabling-technologies area closes first, five weeks after launch. Here is why the sequencing matters and how to read each TA.
Read articlePA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read article